M. McMenemy

Phase 3 randomized 3-month trial with an ongoing 3-month safety extension of fixed-combination brinzolamide 1%/brimonidine 0.2%.

T. Realini, J. Whitson, Q. Nguyen, 2013, Journal of ocular pharmacology and therapeutics : the official journal of the Association for Ocular Pharmacology and Therapeutics.

A Randomized Trial of Fixed-Dose Combination Brinzolamide 1%/Brimonidine 0.2% as Adjunctive Therapy to Travoprost 0.004.

T. Realini, R. Feldman, D. Hubatsch, 2016, American journal of ophthalmology.

Hypotonous maculopathy after trabeculectomy with subconjunctival 5-fluorouracil.

R. Stamper, M. Lieberman, M. McMenemy, 1993, American journal of ophthalmology.

Hypotonous maculopathy after trabeculectomy with subconjunctival 5-fluorouracil.

R. Stamper, M. Lieberman, M. McMenemy, 1993, American journal of ophthalmology.

Six-month results from a Phase III randomized trial of fixed-combination brinzolamide 1% + brimonidine 0.2% versus brinzolamide or brimonidine monotherapy in glaucoma or ocular hypertension

T. Realini, J. Whitson, Q. Nguyen, 2013, Clinical ophthalmology.

Noninferiority Study Comparing Latanoprost 0.005% Without Versus With Benzalkonium Chloride in Open-Angle Glaucoma or Ocular Hypertension

J. Peace, K. Sall, D. Wirta, 2021, Eye & contact lens.

Primary Open Angle Glaucoma

M. McMenemy, Matthew G. McMenemy, 2010 .

Primary Open Angle Glaucoma

M. McMenemy, 2010 .